KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Common Equity (2016 - 2025)

Historic Common Equity for Opko Health (OPK) over the last 16 years, with Q3 2025 value amounting to $1.3 billion.

  • Opko Health's Common Equity fell 697.78% to $1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year decrease of 697.78%. This contributed to the annual value of $1.4 billion for FY2024, which is 171.11% down from last year.
  • Per Opko Health's latest filing, its Common Equity stood at $1.3 billion for Q3 2025, which was down 697.78% from $1.3 billion recorded in Q2 2025.
  • Opko Health's 5-year Common Equity high stood at $1.8 billion for Q3 2021, and its period low was $1.3 billion during Q1 2024.
  • Its 5-year average for Common Equity is $1.5 billion, with a median of $1.5 billion in 2023.
  • As far as peak fluctuations go, Opko Health's Common Equity surged by 971.09% in 2021, and later crashed by 1926.8% in 2024.
  • Quarter analysis of 5 years shows Opko Health's Common Equity stood at $1.7 billion in 2021, then dropped by 7.33% to $1.6 billion in 2022, then dropped by 11.04% to $1.4 billion in 2023, then decreased by 1.71% to $1.4 billion in 2024, then dropped by 4.39% to $1.3 billion in 2025.
  • Its Common Equity stands at $1.3 billion for Q3 2025, versus $1.3 billion for Q2 2025 and $1.3 billion for Q1 2025.